Research, Select, & Monitor Monday, October 15, 2018 8:24:12 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Vera Bradley, Inc.$13.33($.06)(.45%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Vera Bradley, Inc. vs Biotechnology

Vera Bradley Designs, Inc. is a designer, producer, marketer and retailer of accessories for women. Its products include handbags, accessories and travel and leisure items. It sells its products through two reportable segments Indirect and Direct. Its indirect business consists of sale of Vera Bradley products to independent retailers in the U.S. as well as select national retailers and third party e-commerce sites. Its direct business consists of sales of Vera Bradley products through its full-price stores, its outlet stores,, and its annual outlet sale in Fort Wayne, Indiana. Vera Bradley Designs, Inc. is headquartered in Fort Wayne, Indiana.

An exciting industry consisting of companies who develop new drugs to combat such diseases as cancer and other life-threatening diseases. Some may also participate in gene therapy. These firms either bring new drugs to the market themselves (which is a grueling process) or they sell their technology to bigger pharmaceutical companies.
 Totals Company Industry
  Sales: $454.7 Mil $93,638.5 Mil
  Market Cap: $476.3 Mil $494,651.9 Mil
  Analysts Recommendation: Hold Buy

 Averages Company Industry
  Historic Revenue: (6.4%) 45.3%
  Estimated Revenue: (8.6%) 104.1%
  Historic Earnings: (16.7%) (35.9%)
  Estimated Earnings: 4.2% 7.3%
  Stock Price (1 Year): 68.3% 25.3%
  Cash per Share: (18.8%) 19.1%
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: 20.5 28.3
  Price-to-Sales: 1.1 N/A
  Price-to-Book: 1.7 4.3
  Dividend Yield: N/A N/A
  Market Cap: $476.3 Mil $10,753.3 Mil
  Net Margin: 6.3% (972.0%)
  Gross Margin: 55.9% 74.9%
  Return on Equity: .0 (.3)
  Return on Assets: .0 (.3)
  Balance Sheet
  Current Ratio: 6.0 5.1
  Quick Ratio: 3.8 4.7
  Cash Ratio: 3.1 4.0
  Debt-to-Equity: .2 1.0
  Interest Coverage: N/A 1.7
  Relative-Strength Index: 36.5 46.1

 Other companies in Biotechnology Price Market Cap
  Amgen, Inc.  (AMGN) $197.39 $130,277.4 Mil
  Gilead Sciences, Inc.  (GILD) $73.59 $96,255.7 Mil
  Biogen Inc.  (BIIB) $330.94 $68,603.9 Mil
  Celgene Corp.  (CELG) $82.58 $60,498.1 Mil
  Regeneron Pharmaceuticals Inc.  (REGN) $384.16 $43,977.5 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2018 All rights reserved.